Schedule 13D ownership disclosure
GAN LTD
Security class unavailable · CUSIP: G3728V109
Event date: 2021-09-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 694,522
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-21-026353
- Form type
- SC 13D
- Filer
- Indaptus Therapeutics, Inc.
- CIK
- CIK 1857044
- Filed
- Oct 26, 2021
- Reporting period
- Sep 29, 2021
- Description
- Schedule 13D beneficial ownership